Novadip Biosciences
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia. (NCT07112443) | Novadip Biosciences | 2025-09-02 |
| Long-term Safety Trial with NVDX3 (NCT06532253) | Novadip Biosciences | 2024-08-22 |
| Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis (NCT05961956) | Novadip Biosciences | 2023-10-12 |
| Proof-of-concept Study With NVDX3 for Treatment of Distal Radius Fractures. (NCT05987033) | Novadip Biosciences | 2023-08-08 |
| NVD-003 in the Treatment of Congenital Pseudarthrosis of the Tibia (NCT05693558) | Novadip Biosciences | 2022-11-24 |
| Prospective Study in Adults Evaluating Safety & Efficacy of NVD003 for Bone Reconstruction to Treat Lower Limb Nonunion (NCT06335394) | Novadip Biosciences | 2018-08-02 |
| Safety and Preliminary Effectiveness of NVD-001 for the Treatment of Low Grade Degenerative Lumbar Spondylolisthesis (NCT03100032) | Novadip Biosciences | 2017-01-01 |
Track Novadip Biosciences automatically
Every clearance here is in the API, with alerts when new ones post.